The company told Agence France-Presse that Johnson & Johnson of the United States will start delivering vaccines against COVID-19 to Europe on April 19.
Following Pfizer and BioNTech, Modern and AstraZenec, the vaccine was approved by the European Medicines Agency (EMA) in mid-March.
It is currently only available in the United States and South Africa, and has also been approved in Canada. The European Union has ordered 200 million doses of this vaccine and has the option to purchase another 200 million doses.
European Commission President Ursula von der Lein said in mid-March that the EU is expected to receive about 55 million doses in the second quarter of this year.
The company has not yet released a delivery plan.
The vaccine is based on a viral vector, and the company has used this technology for Ebola vaccines.
The vaccine is administered as a single dose and can be stored in the refrigerator.
Croatia has ordered 900,000 doses of this vaccine.